Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer

Published:2012-12-26 Issue:8 Volume:119 Page:1537-1546
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Morris W. James,Keyes Mira,Spadinger Ingrid,Kwan Winkle,Liu Mitchell,McKenzie Michael,Pai Howard,Pickles Tom,Tyldesley Scott

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27911/fullpdf

Reference33 articles.

1. From outcomes research to disease management: a guide for the perplexed;Epstein;Ann Intern Med.,1996

2. Radiation oncology and medical physics quality assurance in British Columbia Cancer Agency's Provincial Prostate Brachytherapy Program [published online ahead of print June 21, 2012];Keyes;Brachytherapy.,2012

3. Population based study of biochemical and survival outcomes after permanent 125 I brachytherapy for low- and intermediate-risk prostate cancer;Morris;Urology.,2009

4. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer;Morris;Int J Radiat Oncol Biol Phys.,2009

5. A proportional hazards model for the subdistribution of a competing risk;Fine;J Am Stat Assoc.,1999

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace® balloon, in patients treated with radiotherapy for prostate cancer;BMC Cancer;2024-08-01

2. Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer;Brachytherapy;2023-03

3. Permanent interstitial low-dose-rate brachytherapy for prostate cancer: institutional experience with implementation and predictive factors for outcome and side effects;Journal of Radiotherapy in Practice;2023

4. Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy;Advances in Radiation Oncology;2022-07

5. Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer;Cancers;2022-04-29